Evaluation of effect of empirical attack-preventive immunotherapies in neuromyelitis optica spectrum disorders: An update systematic review and meta -analysis-Reference-Cited by-同舟云学术

Evaluation of effect of empirical attack-preventive immunotherapies in neuromyelitis optica spectrum disorders: An update systematic review and meta -analysis

Published:2022-02 Issue: Volume:363 Page:577790
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Ma Jia,Yu Haihua,Wang Hao,Zhang Xinghu,Feng Kai

Funder

Natural Science Foundation of Beijing Municipality

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference76 articles.

1. Mechanisms of action of mycophenolate mofetil;Allison;Lupus,2005

2. Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study;Annovazzi;J. Neurol.,2016

3. Longitudinally extensive transverse myelitis in neuromyelitis optica: a prospective study of 13 Caucasian patients and literature review;Bălaşa;Acta Neurol. Belg.,2015

4. Impact of rituximab on relapse rate and disability in neuromyelitis optica;Bedi;Mult. Scler.,2011

5. Neuromyelitis optica treatment: analysis of 36 patients;Bichuetti;Arch. Neurol.,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM);Multiple Sclerosis and Related Disorders;2024-09

2. Impact of rituximab treatment regime on time to relapse in aquaporin-4 antibody positive neuromyelitis optica spectrum disorder;Multiple Sclerosis and Related Disorders;2024-05

3. Efficacy and safety of low- and ultralow-dose rituximab in neuromyelitis optica spectrum disorder;Journal of Neuroimmunology;2024-02

4. Role of regulatory T cells in the pathogenesis and therapeutics of neuromyelitis optica spectrum disorder;Regulatory T Cells and Autoimmune Diseases;2024

5. Rectifying global inequities in neuromyelitis optica diagnosis and treatment;Multiple Sclerosis Journal;2023-06-10